Proliferating Cell Nuclear Antigen (PCNA) Is Required for Cell Cycle-regulated Silent Chromatin on Replicated and Nonreplicated Genes

被引:30
|
作者
Miller, Andrew [1 ,3 ]
Chen, Jiji [2 ,3 ]
Takasuka, Taichi E. [1 ,3 ]
Jacobi, Jennifer L. [1 ,3 ]
Kaufman, Paul D. [4 ]
Irudayaraj, Joseph M. K. [2 ,3 ]
Kirchmaier, Ann L. [1 ,3 ]
机构
[1] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA
[3] Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA
[4] Univ Massachusetts, Sch Med, Program Gene Funct & Gene Express, Slippery Rock, PA 16057 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
ORIGIN RECOGNITION COMPLEX; H3; LYSINE-56; ACETYLATION; DNA-POLYMERASE-DELTA; HISTONE H3; SACCHAROMYCES-CEREVISIAE; EPIGENETIC INHERITANCE; FACTOR-C; S-PHASE; PROTEIN; YEAST;
D O I
10.1074/jbc.M110.166918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Saccharomyces cerevisiae, silent chromatin is formed at HMR upon the passage through S phase, yet neither the initiation of DNA replication at silencers nor the passage of a replication fork through HMR is required for silencing. Paradoxically, mutations in the DNA replication processivity factor, POL30, disrupt silencing despite this lack of requirement for DNA replication in the establishment of silencing. We tested whether pol30 mutants could establish silencing at either replicated or non-replicated HMR loci during S phase and found that pol30 mutants were defective in establishing silencing at HMR regardless of its replication status. Although previous studies tie the silencing defect of pol30 mutants to the chromatin assembly factors Asf1p and CAF-1, we found pol30 mutants did not exhibit a gross defect in packaging HMR into chromatin. Rather, the pol30 mutants exhibited defects in histone modifications linked to ASF1 and CAF-1-dependent pathways, including SAS-I-and Rtt109p-dependent acetylation events at H4-K16 and H3-K9 (plus H3-K56; Miller, A., Yang, B., Foster, T., and Kirchmaier, A. L. (2008) Genetics 179, 793-809). Additional experiments using FLIM-FRET revealed that Pol30p interacted with SAS-I and Rtt109p in the nuclei of living cells. However, these interactions were disrupted in pol30 mutants with defects linked to ASF1- and CAF-1-dependent pathways. Together, these results imply that Pol30p affects epigenetic processes by influencing the composition of chromosomal histone modifications.
引用
收藏
页码:35142 / 35154
页数:13
相关论文
共 50 条
  • [31] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN HUMAN GLIOMAS AND MENINGIOMAS
    BURNS, DK
    MICKEY, BE
    BIGIO, EH
    WHITE, CL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (03): : 362 - 362
  • [32] EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN PRIMARY UVEAL MELANOMA
    WARD, TP
    MCLEAN, IW
    ROBERTS, AO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1926 - 1926
  • [33] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN HODGKINS-DISEASE
    SCHMID, C
    SWEENEY, E
    ISAACSON, PG
    JOURNAL OF PATHOLOGY, 1992, 168 (01): : 1 - 6
  • [34] Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen expression (PCNA)
    Crucitti, A
    Masetti, R
    Breccia, C
    Coppola, R
    Magistrelli, P
    Nuzzo, G
    Picciocchi, A
    8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB, 1998, : 297 - 301
  • [35] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) CYCLIN EXPRESSION DURING THE CELL-CYCLE IN NORMAL AND LEUKEMIC-CELLS
    GIORDANO, M
    DANOVA, M
    PELLICCIARI, C
    WILSON, GD
    MAZZINI, G
    CONTI, AMF
    FRANCHINI, G
    RICCARDI, A
    ROMANINI, MGM
    LEUKEMIA RESEARCH, 1991, 15 (11) : 965 - 974
  • [36] THE PROMOTER OF THE HUMAN PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE IS BIDIRECTIONAL
    RIZZO, MG
    OTTAVIO, L
    TRAVALI, S
    CHANG, CD
    KAMINSKA, B
    BASERGA, R
    EXPERIMENTAL CELL RESEARCH, 1990, 188 (02) : 286 - 293
  • [37] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND RECURRENCE IN PATIENTS WITH CUTANEOUS MELANOMA
    VECCHIATO, A
    ROSSI, CR
    MONTESCO, MC
    FRIZZERA, E
    SENO, A
    PICCOLI, A
    MARTELLO, T
    NINFO, V
    LISE, M
    MELANOMA RESEARCH, 1994, 4 (04) : 207 - 211
  • [38] PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN MEDULLARY-THYROID CARCINOMA
    SKOPELITOU, A
    KORKOLOPOULOU, P
    PAPANIKOLAOU, A
    HADJIYANNAKIS, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (07) : 379 - 381
  • [39] PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOSTAINING IN NEUROBLASTOMA
    KAWASAKI, H
    MUKAI, K
    YAJIMA, S
    TANAKA, R
    TAKAYAMA, J
    TAKASAKI, Y
    OHIRA, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (05): : 300 - 304
  • [40] Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer
    Kovac, D
    Rubinic, M
    Krasevic, M
    Krizanac, S
    Petrovecki, M
    Stimac, D
    Melato, M
    ANTICANCER RESEARCH, 1995, 15 (5B) : 2301 - 2302